Getein Biotech, Inc (603387.SS)
CNY 8.59
(-0.12%)
CNY 8.59
(-0.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 923.09 Million CNY | -22.13% |
| 2022 | 1.18 Billion CNY | 28.96% |
| 2021 | 919.24 Million CNY | 29.83% |
| 2020 | 708.03 Million CNY | 0.46% |
| 2019 | 704.79 Million CNY | 30.16% |
| 2018 | 541.46 Million CNY | 34.95% |
| 2017 | 401.24 Million CNY | 33.87% |
| 2016 | 299.73 Million CNY | 30.94% |
| 2015 | 228.91 Million CNY | 29.86% |
| 2014 | 176.28 Million CNY | 37.07% |
| 2013 | 128.6 Million CNY | 103.02% |
| 2012 | 63.34 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 180.27 Million CNY | -7.5% |
| 2024 Q1 | 229.84 Million CNY | -7.45% |
| 2024 Q2 | 197.92 Million CNY | -13.89% |
| 2023 FY | 923.09 Million CNY | -22.13% |
| 2023 Q3 | 195.7 Million CNY | -3.96% |
| 2023 Q4 | 248.36 Million CNY | 26.9% |
| 2023 Q1 | 275.24 Million CNY | 11.25% |
| 2023 Q2 | 203.78 Million CNY | -25.96% |
| 2022 Q1 | 400.23 Million CNY | 25.82% |
| 2022 FY | 1.18 Billion CNY | 28.96% |
| 2022 Q3 | 283.37 Million CNY | 11.37% |
| 2022 Q2 | 254.45 Million CNY | -36.42% |
| 2022 Q4 | 247.41 Million CNY | -12.69% |
| 2021 Q3 | 208.35 Million CNY | -5.49% |
| 2021 Q2 | 220.45 Million CNY | 27.92% |
| 2021 FY | 919.24 Million CNY | 29.83% |
| 2021 Q1 | 172.34 Million CNY | -24.67% |
| 2021 Q4 | 318.09 Million CNY | 52.67% |
| 2020 Q2 | 149.72 Million CNY | 52.42% |
| 2020 Q4 | 228.77 Million CNY | -1.1% |
| 2020 FY | 708.03 Million CNY | 0.46% |
| 2020 Q1 | 98.23 Million CNY | -61.7% |
| 2020 Q3 | 231.3 Million CNY | 54.49% |
| 2019 Q2 | 166.22 Million CNY | 11.38% |
| 2019 Q4 | 256.49 Million CNY | 93.11% |
| 2019 FY | 704.79 Million CNY | 30.16% |
| 2019 Q3 | 132.82 Million CNY | -20.1% |
| 2019 Q1 | 149.24 Million CNY | -14.95% |
| 2018 Q1 | 118.52 Million CNY | -4.34% |
| 2018 FY | 541.46 Million CNY | 34.95% |
| 2018 Q4 | 175.49 Million CNY | 50.41% |
| 2018 Q3 | 116.67 Million CNY | -10.78% |
| 2018 Q2 | 130.77 Million CNY | 10.33% |
| 2017 Q1 | 75.91 Million CNY | -24.1% |
| 2017 Q2 | 100.35 Million CNY | 32.19% |
| 2017 Q3 | 101.07 Million CNY | 0.71% |
| 2017 Q4 | 123.9 Million CNY | 22.59% |
| 2017 FY | 401.24 Million CNY | 33.87% |
| 2016 Q3 | 64.48 Million CNY | -16.9% |
| 2016 Q1 | 57.63 Million CNY | 0.0% |
| 2016 Q2 | 77.59 Million CNY | 34.64% |
| 2016 Q4 | 100.02 Million CNY | 55.11% |
| 2016 FY | 299.73 Million CNY | 30.94% |
| 2015 Q1 | 48.01 Million CNY | 0.0% |
| 2015 FY | 228.91 Million CNY | 29.86% |
| 2014 FY | 176.28 Million CNY | 37.07% |
| 2013 FY | 128.6 Million CNY | 103.02% |
| 2012 FY | 63.34 Million CNY | 0.0% |